FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management.

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Download full-text PDF
Source

http://dx.doi.org/10.1001/jama.2023.24539 DOI Listing

Download full-text PDF	Source
http://dx.doi.org/10.1001/jama.2023.24539	DOI Listing

Publication Analysis

Top Keywords

fda green-lights

green-lights tirzepatide

tirzepatide marketed

marketed zepbound

zepbound chronic

chronic weight

weight management

fda

tirzepatide

marketed

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!